ML
Myla Lai-Goldman
Founder of GeneCentric Therapeutics
ML
Myla Lai-goldman
Founder of GeneCentric Therapeutics
South Burlington, Vermont
Overview
Myla Lai-Goldman is the Co-Founder and Chair of GeneCentric Therapeutics, Inc., with a background in diagnostics, personalized medicine, and drug development. She has held executive roles at GeneCentric Diagnostics, LabCorp, and currently serves as a Venture Partner at Hatteras Venture Partners.
Highlights of her career include founding GeneCentric Therapeutics, Inc. and serving as the Chief Executive Officer of GeneCentric Diagnostics, Inc., showcasing her expertise in biotechnology and commercialization within the healthcare and pharmaceutical industries.
Work Experience
Co-Founder and Chair
2021 - Current
GeneCentric Therapeutics develops and commercializes molecular diagnostic tests for oncologists and patients.
Raised $41,105,996.00 from IAG Capital Partners.
Venture Partner
2011
Venture Capital Multiplier Fund is a venture capital firm
Managing Partner
2009
It is a consulting company whose mission is to assist its customers achieve successful adoption of innovative diagnostics.
Executive Chair
2019 - 2021
Chief Executive Officer
2011 - 2018
GeneCentric Therapeutics develops and commercializes molecular diagnostic tests for oncologists and patients.
Raised $41,105,996.00 from IAG Capital Partners.
Executive VP, CMO & CSO
1990 - 2008
LabCorp Venture Fund invests in early stage private companies operating in current or strategically adjacent spaces.